Metabolomics Services Market Present Scenario and the Growth Prospects with Forecast 2022-28

According to Precision Business Insights (PBI) latest report The Global Metabolomics Services market is expected to be worth USD 111.5 million in 2021, growing at a 16% CAGR from 2022 to 2028. Metabolomic studies are gaining traction in the life sciences sector because they can show the optimal amount of certain metabolites linked to disease onset/progression, as well as therapy exposure and response. With the rising mortality rates of life-threatening diseases such as cancer and cardiovascular disease (CVD), researchers are focusing more on creative techniques that might provide better diagnosis and therapy. Additional study is being undertaken on this subject since metabolomics is considered a revolutionary method with significant promise. In addition, metabolomic indicators have become more important in medication development in recent years. Government and private investments in metabolomics research are expanding as a result of these reasons.

View Detailed Report Description Here - https://precisionbusinessinsights.com/market-reports/global-metabolomics-services-market/

Healthcare Industry Segment are Dominate the Metabolomics Services Market:
Based on end user, the metabolomic services market has been segmented into Healthcare Industry, Academic and Research Institutes, Food Processing Industry, and Others. Healthcare industry accounted to have largest share and the market is expected to grow at prominent growth rate over the forecast years owing to increase in R&D for drug discovery and biomarker discovery coupled with technological advancements and rise in chronic disease prevalence and an increase in recognition for current diagnostics procedures. During the forecast period, the customized medicine market is expected to develop at the fastest rate.

North America Leads Metabolomics Services Market:
North America which includes US and Canada, is expected to hold more than 50% market share in the global metabolomics services market in the forecast period, and it is projected to grow at a CAGR of X% in the coming years. North America region can be attributed to the presence of major players operating in the metabolomics market in the US, growing biomedical research in the US, and rising preclinical activities by CROs and pharmaceutical companies in the region.

Request sample report at https://precisionbusinessinsights.com/request-sample?product_id=16500

Strategic New Product Launches, Mergers, Acquisitions and Agreements are the key strategies adopted by market players:
Global metabolomics services market further reveals that the key players increasingly adopting strategies such as launch of newer products, product launches, and long-term alliance to improve market revenue share and gaining significant geographic presence across the region. For instance, In 2018, Metabolon, Inc., one of the leading company in the field of metabolomics, had a debt refinancing agreement with Innovatus Capital Partners, LLC and East West Bank to provide a $30 million debt facility to pay off an existing term loan and fund laboratory expansion necessary to meet increased demand for metabolomic testing services.

Detailed Segmentation
Based on the Service Type, the market is segmented into the following:
• Separation & detection
• Bio informatics Services

Based on the Sample Type, the market is segmented into the following:
• Urine
• Tumor
• Cell Culture
• Blood
• Food Ingredients
• Feces

Based on the Sample Source, the market is segmented into the following:
• Human
• Animal
• Others

Based on the End User, the market is segmented into the following:
• Healthcare Industry
• Academic and Research Institutes
• Food Processing Industry
• Others

Request Methodology: https://precisionbusinessinsights.com/request-methodology?product_id=16500

Key player's profiles in the Metabolomics Services market report are Waters Corporation (US), Agilent Technologies (US), Shimadzu Corporation (Japan), Thermo Fisher Scientific (US), Danaher Corporation (US), Bruker Corporation (US), PerkinElmer (US), Merck KGaA (Germany), GE Healthcare (US), Hitachi High-Technologies Corporation (Japan), Human Metabolome Technologies, Inc. (Japan), LECO Corporation (US)

Contact:
Mr. Satya
Precision Business InsightsTM | Toll Free: +1 866 598 1553
Email: sales@precisionbusinessinsights.com
Kemp House, 152 - 160 City Road, London EC1V 2NX
Web: https://precisionbusinessinsights.com/ | D U N S® Number: 852781747

About Precision Business Insights:
We are a market research company that strives to provide the highest quality market research insights. Our diverse market research experts are enthusiastic about market research and therefore produce high-quality research reports. We have over 500 clients with whom we have a good business partnership and capacity to provide in-depth research analysis for more than 30 countries. In addition to deliver more than 150 custom solutions, we already have accounts with the top five medical device manufacturers.

Precision Business Insights offers a variety of cost-effective and customized research services to meet research requirements. We are a leading research service provider because of our extensive database built by our experts and the services we provide.

This release was published on openPR.